Beruflich Dokumente
Kultur Dokumente
Lyssavirus Vesiculovirus
Rabies virus:
single-strand RNA virus
Epidemiology
• Worldwide zoonotic disease:
• 55,000 deaths/year: ~31,000 in Asia (mostly
India), ~24,000 in Africa
• Endemic in the Philippines – among the top 10
countries with a rabies problem
• ~ 200 to 300 rabies cases per year
p. 1613
Pathogenetic events following peripheral
inoculation of rabies virus (Fig 195-2)
Choose the best answer:
The most characteristic pathologic finding
in rabies is:
A. Babes nodules
B. Degenerative neuronal changes
C. Negri bodies
D. Neuronophagia
Choose the best answer:
The most characteristic pathologic finding
in rabies is:
A. Babes nodules—microglial nodules can be
seen but not the distinguishing hallmark of
rabies (p. 1612)
B. Degenerative neuronal changes—
dysfunction rather than degeneration
C. Negri bodies—eosinophilic cytoplasmic
inclusions in brain neurons containing rabies
virus proteins and viral RNA
D. Neuronophagia—neuronal destruction by
phagocytes seen occasionally
Negri bodies
Modified true or false:
Management of rabies:
A. Rabies postexposure prophylaxis (PEP)
can effectively prevent rabies.
B. PEP includes local wound care and both
active and passive immunization.
C. Give rabies immune globulin IV and
rabies vaccine IM if a patient has been
bitten by a dog.
D. There is no effective treatment for rabies.
Modified true or false:
Management of rabies:
A. Rabies postexposure prophylaxis (PEP) can
effectively prevent rabies.--T
B. PEP includes local wound care and both
active and passive immunization.--T
C. Give rabies immune globulin IV and rabies
vaccine IM if a patient has been bitten by a
dog.—F (RIG at site of wound, or IM if
mucous membrane is affected area)
D. There is no effective treatment for rabies.—T
pp. 1615-6
PSMID-PFV 2012 Handbook:
Indications
• When person is bitten by a rabid person or
animal
• When the saliva or other potentially
infectious material such as neural tissue
has contaminated an open wound or
mucous membrane
• All persons exposed to rabid or suspect
rabid animals or persons
PSMID-PFV 2012 Handbook:
Categories of exposure to rabid animals/persons
• Category I: touching or feeding of animals or
persons, lick on intact skin
• Pre-exposure prophylaxis may be recommended
• Category II: nibbling of uncovered skin, minor
scratches or abrasion w/o bleeding, licks on
broken skin
• Post-exposure prophylaxis MUST be administered
• Category III: single or multiple transversal bits or
scratches, contamination of mucous membranes
with saliva; all Category II exposures on the head,
face or neck
• Post exposure prophylaxis MUST be administered
TETANUS
Chapter 140, Harrison 18e
Choose the best answer:
The neurotoxin that causes the clinical
manifestations of tetanus is:
A. Streptolysin
B. Synaptobrevin
C. Tetanolysin
D. Tetanospasmin
Choose the best answer:
The neurotoxin that causes the clinical
manifestations of tetanus is:
A. Streptolysin – related to tetanolysin but no role
in pathogenesis of tetanus
B. Synaptobrevin – aka VAMP2
• needed for presynaptic binding & release of
neurotransmitter. Tetanus toxin cleaves VAMP2, thus
preventing transmitter release and bloacking
inhibitory interneuron discharge
C. Tetanolysin – the other exotoxin produced by C.
tetani but no role in pathogenesis
D. Tetanospasmin – transported to motor nuclei
of the cranial nerves or ventral horns of the
spinal cord. p. 1197
Choose the best answer:
The diagnosis of tetanus is mainly by:
3 or more No No No No
doses (yes, if > (yes if >
10 yrs 10 yrs
since last since last
Td) Td)
MALARIA
Chapter 210, Harrison 18e
Malaria transmission cycle
Modified true or false:
Pathogenetic events in malaria:
A. Hemolysis
B. Parasitemia >100,000/ul
C. Respiratory alkalosis
D. Thrombocytosis
Choose the best answer:
Indicator/s of poor prognosis in severe
falciparum malaria:
A. Hemolysis
B. Parasitemia >100,000/ul (p.1692)
C. Respiratory alkalosis
D. Thrombocytosis
Treatment of malaria
___ 1. Drug of choice for P. A. Amodiaquine
vivax in Asia except in B. Artemether-
PNG & Indonesia lumefrantrine
___ 2. First-line drug for P. C. Artesunate IV
falciparum in the D. Chloroquine
Philippines
E. Primaquine
___ 3. Radical treatment
for P. vivax F. Quinine IV
___ 4. Severe falciparum G. Sulfadoxine-
malaria pyrimethamne
Treatment of malaria (p. 1698)
D 1. Drug of choice for P. A. Amodiaquine
vivax in Asia except in B. Artemether-
PNG & Indonesia lumefrantrine
B 2. First-line drug for P. C. Artesunate IV
falciparum in the D. Chloroquine
Philippines
E. Primaquine
E 3. Radical treatment
for P. vivax F. Quinine IV
F/C 4. Severe falciparum G. Sulfadoxine-
malaria pyrimethamne
Drugs used for malaria prophylaxis